Kristin Austria, NP
Nurse Practitioner · Virginia Beach, VANPI 1750893434
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 84.2% of it on its own, with 12 other manufacturers making up the rest. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $100.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$22K
- Medtronic$1K
- Sumitomo Pharma America, Inc.$749
- Coloplast$517
- Endo Pharmaceuticals Inc.$346
- C. R. Bard, Inc. & Subsidiaries$319
- plus $744 from 7 others
What the payments were for
- Consulting fees$6703%
- Speaking & faculty fees$12,76650%
- Travel & lodging$8,41833%
- Food & beverage$3,39713%
- Education$3641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $21,570 |
| Medtronic | 24 | $1,370 |
| Sumitomo Pharma America, Inc. | 60 | $749 |
| Coloplast | 52 | $517 |
| Endo Pharmaceuticals Inc. | 17 | $346 |
| C. R. Bard, Inc. & Subsidiaries | 19 | $319 |
| Astellas Pharma US Inc | 3 | $237 |
| Urovant Sciences Inc | 16 | $131 |
| Pfizer | 2 | $118 |
| SRS Medical Systems, Inc. | 1 | $110 |
| Axonics, Inc. | 1 | $94 |
| Teleflex LLC | 2 | $31 |
| Vertex | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$20,880
- INTERSTIM$914
- GEMTESA$125
- XIAFLEX$110
- CT3000 Pro Base Unit$110
- UroCuff-DC Disposable, Single$110
How this compares
$25,616 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 387 | $374,352 |
| MyrbetriqMirabegron | 235 | $203,506 |
| Mirabegron ErMirabegron | 33 | $26,965 |
| Trospium Chloride | 243 | $26,340 |
| Estradiol | 274 | $19,740 |
| Trospium Chloride ErTrospium Chloride | 75 | $16,287 |
| PremarinEstrogens, Conjugated | 28 | $13,018 |
| Darifenacin ErDarifenacin Hydrobromide | 69 | $8,658 |
| Tamsulosin Hcl | 231 | $3,519 |
| Trimethoprim | 49 | $2,526 |
| Tolterodine Tartrate ErTolterodine Tartrate | 17 | $2,354 |
| Methenamine Hippurate | 18 | $1,702 |
| Desmopressin Acetate | 20 | $1,442 |
| Solifenacin Succinate | 40 | $1,225 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 23 | $997 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $749 | $374,352387 claims |
| Astellas Pharma US IncMyrbetriq | $237 | $203,506235 claims |
| PfizerPremarin | $118 | $13,01828 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Virginia Beach
- Kimberly ClovisVirginia Beach$14K
- Lisa WalkerVirginia Beach$11K
- Barbara McCrayVirginia Beach$10K
- Matthew GilbertVirginia Beach$10K
- Colette BrooksVirginia Beach$9K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.